Ongoing investigation reminder: the schall law firm announces it is investigating claims against sarepta therapeutics, inc. and encourages investors with losses of $100,000 to contact the firm

Los angeles, california--(newsfile corp. - february 8, 2021) - the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of sarepta therapeutics, inc. ("sarepta" or "the company") (nasdaq: srpt) for violations of the securities laws.the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. sarepta announced that its one-time gene therapy for duchenne muscular dystrophy...
SRPT Ratings Summary
SRPT Quant Ranking